Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Acular/Acular LS (Ketorolac Tromethamine) Prescribers: Ophthalmologists (US)

Articles with lock require a subscription to GLG News | Request a free trial
July 2, 2007
SMOKING INCREASES RISK OF BLINDNESS DUE TO MACULAR DEGENERATION
Analysis of: European Eye Study Links Cigarette Smoking to Age-Related Macular Degeneration | www.ophsource.org
Author: GLG Expert Contributor
The European Eye Study (EUREYE) investigated 4,750 randomly sampled people over age 65 and examined the association between cigarette smoking and age-related macular degeneration and concluded that there is a postive correlation to smoking and blindness from macular degeneration.
July 2, 2007
AMO will Push Hard to Increase INTRALASE Penetration in the LASIK Market in 2008 and Beyond
Analysis of: Femtosecond Laser for Penetrating Keratoplasty | www.ajo.com
Author: GLG Expert Contributor
In this latest study with the Intralase femtosecond laser, we see its versatility in being able to produce very efficient and safe corneal cuts for corneal transplant surgery. In addition to producing significant benefits for patients that undergo LASIK, this laser has thereaputic benefits that will...
July 2, 2007
DELIVERY SYSTEM OF NEW MACULAR DEGENERATION DRUGS MAY BECOME VERY IMPORTANT
Analysis of: Intravitreous Dexamethasone Drug Delivery System in Patients With Persistent Macular Edema | archopht.ama-assn.org
Author: GLG Expert Contributor
A study reported in the March issue of Archives of Ophthalmology describes a new intravitreous drug delivery system for treating persistent retinal macular swelling. Using dexamethasone DDS and appropriate follow up, patients with this new system had significantly improved vision and and safety mea...
July 2, 2007
ANti VGEF THERAPIES ARE NOT JUST FOR MACULAR DEGENERATION
Analysis of: Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage | www.retinajournal.com
Author: GLG Expert Contributor
A study by Costa et al. reported in the prestigopis journal RETINA, of seven seven patients with macular SWELLING associated with ischemic retinal vein occlusion treated with intravitreal bevacizumab showed promising short-term results. Patients received two injections of bevacizumab (Avastin)...
July 2, 2007
PHAKIC IOLS ARE NOT DEAD
Analysis of: Artisan Phakic Intraocular Lens Safe, Effective After 10 Years | www.ophsource.org
Author: GLG Expert Contributor
Tahzib et al. conducted a 10-year retrospective follow-up study of the Artisan phakic intraocular lens (PIOL) for the correction of moderate to high nearsigtedness and concluded the device is both stable and predictable, but only when strict inclusion criteria are used. Over 90% of patients achieved...
May 21, 2007
VEGF Trap continues to show promising data for wet AMD Treatment
Analysis of: Vegf Trap-Eye Phase 2 Wet Amd Results Reported At Arvo Annual Meeting | www.pipelinereview.com
Author: GLG Expert Contributor
The VEGF Trap from Regeneron is a protein made up off human VEGF receptors fused to human immunoglobulin. This compound binds VEGF, preventing VEGF from binding to its natural receptors, interrupting the angiogenic cascade. The phase II study presented at 2007 ARVO showed promising results in patients...
May 21, 2007
Therapy with PDT is worthless in the world of anti-VEGF agents
Analysis of: Ranibizumab, PDT combination successfully treats neovascular AMD | www.osnsupersite.com
Author: GLG Expert Contributor
At the recent ARVO meeting, Italian researchers performing a randomized clinical trial on patients with wet AMD found that patients treated with photodynamic therapy (PDT) with Visudyne (verteporfin, Novartis) plus Lucentis(ranibizumab, Genentech) had a better visual result than patients treated with...
April 17, 2007
Staar is a Weak Performer in Ophthalmology
Analysis of: Toric lens approval unlikely this year, STAAR Surgical says | www.ophthalmologytimes.com
Author: GLG Expert Contributor
For a company that has had its share of rejections and problems with the approval of a phakic IOL (ICL Visian)  that it tried to have enter the US market almost a decade ago, things are not improving much for Staar.  The company recently reported that despite its request over one year ago...
April 17, 2007
Multifocal IOLS are In their Infancy
Analysis of: Better Vision Without Looking Your Age | www.nytimes.com
Author: GLG Expert Contributor
Mutifocal iols are currently used to try to correct distance and near vision.  While patients are often pleased by their improved near vision without glasses, many complain of poor optical quality for distance vision.  Due to great out of pocket costs and poor quality of vision under some...
April 16, 2007
Wait and See Before More Serious Action Taken
Analysis of: Researchers report 13 cases of MRSA keratitis after laser refractive surgery | www.osnsupersite.com
Author: GLG Expert Contributor
These cases may just be an isolated incident and the report of one or two cases clearly creates attention to the infection and awareness for further cases. In the over 11 years since laser vision correction has been approved in the USA we have not seen much incidence of these infections, so we must...

Previous Page : 1 2 3 4 5 6 Next21 to 30 of 56

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-01T17:45:17.637